Testing a standard MRSA decolonization treatment showed that while it successfully cleared the bacteria in most carriers, it also caused long-lasting disruptions to their nasal microbiomes.

A clinical trial comparing a single daily tablet for ulcerative colitis to three tablets found that both treatments resulted in similar patient adherence and disease relapse rates.

A study of ulcerative colitis patients after pouch surgery found that half experienced pouchitis, but urgent surgery did not increase this risk, and overall pouch failure was low.

By analyzing a century of data from 522 global studies, researchers mapped the real-world progression of inflammatory bowel disease, confirming its transition through four previously theoretical epidemiological stages.

An AI system tested for classifying ulcerative colitis severity from endoscopy videos matched expert accuracy and improved the diagnostic performance of non-specialist doctors.

This study analyzed predictors of ulcerative colitis remission, finding that older age and higher disability reduced its likelihood, while longer disease duration and moderate activity increased it.

Testing anti-TNF therapy in patients with inflammatory bowel disease showed that while most responded initially, about a quarter to a third eventually lost response during maintenance therapy.

A study of ulcerative colitis patients starting biological therapy found that severe baseline tissue inflammation, but not endoscopic activity, independently predicts a higher risk of colon removal.

A clinical trial testing Trichuris suis ova for moderate ulcerative colitis found that the treatment was not superior to placebo in achieving clinical remission at 24 weeks.

A study of Danish patients found that using specific classes of antibiotics is associated with a significantly increased risk of inflammatory bowel disease flare-ups.

Analyzing a century of global data, researchers mapped how inflammatory bowel disease transitions through distinct epidemiological stages, confirming its progression from low incidence to compounding prevalence.

A systematic review found that fecal microbiota transplantation was no more effective than a placebo at improving short-term symptoms in patients with chronic pouchitis.

Testing ulcerative colitis patients starting biological therapy, researchers found that baseline gut tissue inflammation significantly predicted the risk of colon removal, while clinical and endoscopic symptoms did not.

By examining elderly inflammatory bowel disease patients before death, researchers found that hospitalizations, corticosteroid prescriptions, and disease relapses spiked during the final two months of life.

An AI model tested for evaluating ulcerative colitis severity from endoscopy videos matched expert accuracy and improved the diagnostic performance of non-specialist doctors.

A review of fecal microbiota transplantation for irritable bowel syndrome found insufficient evidence to support its use, as it did not significantly improve symptoms compared to a placebo.

Researchers tested a new algorithm for identifying inflammatory bowel disease patients in Denmark's national registry, finding it is more accurate than the currently used method.

Tracking adults with gastrointestinal conditions during the pandemic, this study found a reciprocal relationship between gastrointestinal symptoms and psychological distress.

A study testing surgery timing in Crohn's disease patients found that undergoing surgery within 29 days of diagnosis reduced the risks of repeat surgery and subsequent medication use.

Researchers studying Inflammatory Bowel Disease (IBD) in Denmark found its incidence, for both children and adults, continuously rose to among the world's highest.

A survey of European hepatologists found significant variations in how primary sclerosing cholangitis patients are treated and monitored for related conditions.

An AI model was developed and tested to automatically classify ulcerative colitis severity from endoscopic images, achieving high accuracy (up to 0.94) across different severity levels.

This study tested COVID-19 fear in IBD patients versus other GI conditions, finding IBD patients experienced more GI-specific fear, especially if on sick leave or in rural settings.

Researchers investigated factors predicting biological drug failure in IBD patients, finding ulcerative colitis increased non-response and loss of response, but immunomodulators reduced risk.

This study tested fear of COVID-19's impact on quality of life in IBD patients, finding it mediates GI symptom effects on QoL.

Artificial intelligence was shown to assist in assessing endoscopic inflammatory bowel disease activity.

This planned international study will evaluate the COVID-19 pandemic's impact on gastrointestinal symptoms and well-being in people with chronic GI disorders to guide targeted healthcare support.

Testing newly diagnosed ulcerative colitis patients, researchers found that microscopic inflammation in normal-looking colon tissue predicts a higher risk of future complications and stronger treatment needs.

This study found people with Inflammatory Bowel Disease (IBD) had greater disease-specific COVID-19 fears than other gastrointestinal patients.

An AI model was tested on endoscopic images of ulcerative colitis patients and found to accurately distinguish different levels of disease activity.

Researchers tested single histological features in limited ulcerative colitis, finding neutrophils in over 50% of crypt epithelium predict higher disease complications.

This systematic review tested osteoporosis prevalence in IBD patients, finding Crohn's disease links to higher risk, especially with lower weight and BMI.

Testing of the Danish National Patient Registry revealed it accurately identifies inflammatory bowel disease patients and their age at diagnosis, but is unreliable for detailed disease classification.

Daily probiotics in obese pregnant women did not affect weight gain, diabetes, or infant birth weight, but did modulate their gut microbiota.

This review will examine fecal microbiota transplantation versus placebo to determine benefits and harms for irritable bowel syndrome patients.

In IBD patients, osteoporosis incidence was significantly higher than controls, but bone density screening was infrequent.

This study found that patients with Crohn's disease and ulcerative colitis have an increased overall and site-specific risk of extra-intestinal cancers.

A study assessed the Danish National Patient Registry's reliability for IBD data, finding it good for identifying patients and age, but unreliable for detailed disease classification.

Probiotic supplements were tested in obese pregnant women, showing they are feasible and can change gut bacteria, but did not significantly impact weight or diabetes.

This study tested paediatric versus adult IBD patients and found that children had more extensive disease, higher complication rates, and increased need for treatments and experienced more relapses.

This study tested inflammatory bowel disease patients' quality of life, finding it similar to the general population, yet reduced by unemployment, sick leave, and disease activity.

This study assessed inflammatory bowel disease costs, finding direct costs high due to hospitalisation, but indirect costs did not exceed controls.

This study assessed combined direct and indirect costs of inflammatory bowel disease, finding high direct costs but indirect costs similar to controls.

IBD patients face a higher osteoporosis risk, but this study found their bone density screening is inadequate, especially for those on steroid treatment.

A study on Crohn's patients revealed that perianal disease increases long-term risks of surgery and hospitalization, signaling a more severe disease course.

Fecal transplants changed gut bacteria in IBS patients, but placebo capsules led to greater symptom improvement.

Researchers validated a Danish version of the inflammatory bowel disease disability index, finding that Crohn's disease, active illness, and steroid use are linked to higher disability.

By profiling colon tissue from 94 people, researchers found that just 35 gene-regulating sites can distinguish Crohn’s disease, ulcerative colitis, and healthy controls with 85% accuracy.

This study found that despite new treatments, the risk of surgery and hospitalisation for inflammatory bowel disease remains high.

Researchers studied IBD treatment changes over 10 years, finding Crohn's patients more often needed advanced therapies than UC patients.

This study tested risk factors for perianal Crohn's disease and found colon involvement and penetrating disease predict its development, leading to more surgery and hospitalizations.

This review tested the Inflammatory Bowel Disease Disability Index and found it a reliable tool, showing active disease increases disability while biological treatments decrease it.

Changing disease location or behavior predicted worse Crohn's disease outcomes, while biologics helped prevent location changes.

This MIT M. Eng. thesis record provides no details on tested methods or research findings.